Health
ACROFAN – ACROFAN USA
Preclinical data show Clover’s protein-based adjuvanted COVID-19 vaccine candidate, S-Trimer, induces a strong neutralizing immune response in animalsand protects nonhuman primates from SARS-CoV-2 challengeStrong immune response and protection observed with a…
- Preclinical data show Clovers protein-based adjuvanted COVID-19 vaccine candidate, S-Trimer, induces a strong neutralizing immune response in animalsand protects nonhuman primates from SARS-CoV-2 challenge
- Strong immune response and protection observed with adjuvant systems from GSK and Dynavax led to inclusion of both adjuvants separately into Clovers ongoing Phase 1 clinical trial of S-Trimer
- Clovers ongoing Phase 1 trial of S-Trimer COVID-19 vaccine c…
Continue Reading
